Palleon Pharmaceuticals

Palleon Pharmaceuticals

Palleon Pharmaceuticals

Palleon is targeting glycan-sensing checkpoints to unleash both the innate and adaptive immune responses to cancer.
Raised
$48M
Follow us
Alexa global traffic share